Chimeric antigen receptor macrophage therapy for breast tumours mediated by targeting the tumour extracellular matrix

BACKGROUND: The extracellular matrix (ECM) is essential for malignant tumour progression, as it is a physical barrier to various kinds of anticancer therapies. Matrix metalloproteinase (MMPs) can degrade almost all ECM components, and macrophages are an important source of MMPs. Studies using macrop...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wenlong, Liu, Ling, Su, HuiFang, Liu, Qin, Shen, Jie, Dai, Hanren, Zheng, Wei, Lu, Yan, Zhang, Weijie, Bei, Yuncheng, Shen, Pingping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889154/
https://www.ncbi.nlm.nih.gov/pubmed/31570753
http://dx.doi.org/10.1038/s41416-019-0578-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889154/
https://www.ncbi.nlm.nih.gov/pubmed/31570753
http://dx.doi.org/10.1038/s41416-019-0578-3

Ejemplares similares